Neville Rodie & Shaw’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-4,000
| Closed | -$271K | – | 251 |
|
|
2022
Q4 | $271K | Sell |
4,000
-1,600
| -29% | -$108K | 0.03% | 222 |
|
|
2022
Q3 | $279K | Hold |
5,600
| – | – | 0.03% | 217 |
|
|
2022
Q2 | $312K | Sell |
5,600
-16,490
| -75% | -$919K | 0.03% | 215 |
|
|
2022
Q1 | $1.25M | Hold |
22,090
| – | – | 0.09% | 122 |
|
|
2021
Q4 | $1.24M | Buy |
+22,090
| New | +$1.24M | 0.09% | 128 |
|
|
2017
Q2 | – | Sell |
-24,700
| Closed | -$423K | – | 255 |
|
|
2017
Q1 | $423K | Sell |
24,700
-11,150
| -31% | -$191K | 0.05% | 184 |
|
|
2016
Q4 | $643K | Sell |
35,850
-3,600
| -9% | -$64.6K | 0.08% | 155 |
|
|
2016
Q3 | $820K | Buy |
39,450
+112
| +0.3% | +$2.33K | 0.1% | 141 |
|
|
2016
Q2 | $1.06M | Sell |
39,338
-1,126
| -3% | -$30.3K | 0.13% | 121 |
|
|
2016
Q1 | $1.1M | Sell |
40,464
-1,070
| -3% | -$29K | 0.13% | 121 |
|
|
2015
Q4 | $1.21M | Sell |
41,534
-890
| -2% | -$25.8K | 0.15% | 116 |
|
|
2015
Q3 | $1.15M | Buy |
42,424
+3,070
| +8% | +$83.2K | 0.14% | 123 |
|
|
2015
Q2 | $1.08M | Sell |
39,354
-530
| -1% | -$14.5K | 0.12% | 130 |
|
|
2015
Q1 | $1.06M | Hold |
39,884
| – | – | 0.11% | 138 |
|
|
2014
Q4 | $844K | Sell |
39,884
-120
| -0.3% | -$2.54K | 0.09% | 153 |
|
|
2014
Q3 | $952K | Hold |
40,004
| – | – | 0.09% | 143 |
|
|
2014
Q2 | $924K | Buy |
40,004
+8,604
| +27% | +$199K | 0.09% | 139 |
|
|
2014
Q1 | $716K | Sell |
31,400
-156,850
| -83% | -$3.58M | 0.08% | 137 |
|
|
2013
Q4 | $696K | Buy |
188,250
+150,600
| +400% | +$557K | 0.08% | 139 |
|
|
2013
Q3 | $638K | Hold |
37,650
| – | – | 0.07% | 141 |
|
|
2013
Q2 | $584K | Buy |
+37,650
| New | +$584K | 0.07% | 146 |
|